4-(Pyridin-4-yl)pyridazine

Catalog No.: 
ACFAFH038
CAS No.: 
343787-96-2
Molecular Formula: 
C9H7N3
Molecular Weight: 
157.18
4-(Pyridin-4-yl)pyridazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$247.00InquiryInquiry
250mg97%$592.00InquiryInquiry
1g97%$1480.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Pyridin-4-yl)pyridazine
IUPAC Name4-(pyridin-4-yl)pyridazine
MDL No.MFCD28579101
Molecular FormulaC9H7N3
Molecular Weight157.18
SMILESC1(C2=CC=NC=C2)=CC=NN=C1
InChI KeyQZBDEUCWKDAUML-UHFFFAOYSA-N
Synonym4-pyridin-4-ylpyridazine;Pyridazine, 4-(4-pyridinyl)-
CAS No.343787-96-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFAFH038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTGDK423 route compound structure diagram
    ACTGDK4231220039-64-4In Stock
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACFAFH038 route product structure diagram
    ACFAFH038343787-96-2
Inquiry

2. ACFAFH038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1In Stock
  4. Then
  5. ACFAFH038 route product structure diagram
    ACFAFH038343787-96-2
Inquiry

3. ACFAFH038 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTGDK423 route compound structure diagram
    ACTGDK4231220039-64-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFAFH038 route product structure diagram
    ACFAFH038343787-96-2
Inquiry

Comments (0)